For Medtech and diagnostic industry professionals, Medtech Insight is a time-saving, trusted source for industry data, opinion, analysis and news to inform deal making and business cases for product development, launch and market growth.
Medtech Insight goes beyond the headlines and focusses on delivering intelligence and analysis to help you plan product strategy and keep up to date with the latest clinical practices.
A subscription to Medtech Insight will give you access to the latest licensing opportunities, partnership deals, technology developments and regulatory issues whilst constantly tracking product approvals across multiple therapy areas and product types.
Subscribers benefit from increased global content thereby keeping themselves ahead of competition; track new technologies that are in the pipeline; what stage of clinical trials they are at, and those that have just arrived on the market.
More data and trends so you can become better at tracking approvals, interpret compliance and enforcement data and make sense of regulatory documents and their implications. This gives you the ability to evaluate the trends and assess what they mean for the future.
Medtech Insight now also publishes in-depth profiles of leading-edge start-up companies including new trends in business, technology, and financing. This will help you to identify new investment opportunities, create technology/product ideas and help you understand key trends in company start-ups and plan strategically for the future.
Leading industry insight on a leading industry platform
Medtech Insight is published on a new user-friendly, interactive and responsive website. It allows you to access a large amount of relevant content from one place. The ability to create custom email alerts numerous ways to refine search results, and collect, send and share content allows you to tailor the service to your exact requirements.
Related articles, deals, companies, regions, therapy areas and other subjects are listed on the same page. This means that you can identify, find and read the content without having to look for it, making the website a valuable time saving resource.
Subscribe today and get access to:
- Over 14 senior experienced journalists based in Europe, US and Asia to bring you real-time analysis, news and opinion accessible on mobile, tablet and PC.
- Regular, detailed updates on policies coming out of FDA, the EU, OUS and bodies focused on
- global harmonization.
- Analysis of regulatory/policy themes and interviews with key decision makers and experts.
- Regulatory Developments: Including approvals, compliance and enforcement data, regulatory documents and other data.
- Deep analysis and opinion offered around key regulatory events.
- Company Developments: Including M&A, deals, financial results, partnerships and more.
- Product Developments: Including clinical trial results, approvals, launches, postmarketing updates so you can drive your own new product strategy.
- In-depth profiles of leading-edge companies assessing new trends and technologies.
- Create email alerts tailored to your needs and refine using faceted search.
- “Ask the Analyst” exclusive client service to find out more about market access topics, developments, or trends to support presentations, proposals, or business critical decisions where your credibility is on the line.
To Speak with a Sales Representative:
If you would like to speak with one of our knowledgeable Sales Representatives, please reach out as follows:
- Email: PharmaNewsSales@informa.com
- Phone (US) +1 212-520-2765
- Phone (UK & Europe): +44 (0) 20 7017-4191
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.